[F1Interpretation of this PartU.K.
This section has no associated Explanatory Memorandum
124A. In this Part, “relevant list” means—
(a)the list referred to in Article 16f(1) of the 2001 Directive, as that list may be amended from time to time; or
(b)if the licensing authority publishes a list under regulation 126A(1), that list.]
Textual Amendments
F1Reg. 124A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 109; 2020 c. 1, Sch. 5 para. 1(1)